Eris Lifesciences Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimisave MV 1.3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimisave MV 1.3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimisave MV 1.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimisave MV 1.3 Tablet SR.
Glimisave MV 1.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimisave MV 1.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimisave MV 1.3 Tablet SR is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimisave MV 1.3 Tablet SR contains a combination of Glimepiride, Metformin, and Voglibose, which are used to treat Type 2 diabetes mellitus (DM). This medication helps improve blood glucose levels by increasing insulin release from the pancreas and by reducing glucose production in the liver. It works by lowering postprandial glucose levels through Voglibose's action as an alpha-glucosidase inhibitor. It is not indicated for treating Type 1 DM.
Possible side effects of using Glimisave MV 1.3 Tablet SR include hypoglycemia (low blood sugar levels), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
It's crucial to avoid using this medication if you are allergic to any component of the medicine, or if you have severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, it's not safe to combine alcohol with Glimisave MV 1.3 Tablet SR. It may lower your blood sugar levels (hypoglycemia) and increase the chances of lactic acidosis.
Yes, using Glimisave MV 1.3 Tablet SR can lead to hypoglycemia (low blood sugar levels). Common symptoms of this condition include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It's more likely to occur when missing meals, drinking alcohol, over-exercising, taking other antidiabetic medications simultaneously, and delaying food intake. Regular blood sugar monitoring is essential, along with carrying glucose tablets, honey, or fruit juice for emergencies.
Store Glimisave MV 1.3 Tablet SR in its original packaging, tightly closed. Follow the instructions on the label or medication pack for storage duration. Ensure that unused medicine is disposed of appropriately and not consumed by pets, children, or others.